Symbol:
Ugp2
Name:
UDP-glucose pyrophosphorylase 2
RGD ID:
1310210
Description:
Enables D-glucose binding activity; UTP:glucose-1-phosphate uridylyltransferase activity; and pyrimidine ribonucleotide binding activity. Involved in UDP-alpha-D-glucose metabolic process and glucose 1-phosphate metabolic process. Predicted to be active in cytoplasm. Human ortholog(s) of this gene implicated in developmental and epileptic encephalopathy 83. Orthologous to human UGP2 (UDP-glucose pyrophosphorylase 2); PARTICIPATES IN congenital sucrase-isomaltase deficiency pathway; galactokinase deficiency pathway; galactose metabolic pathway; INTERACTS WITH 17beta-estradiol; 2,2',4,4'-Tetrabromodiphenyl ether; 2,3,7,8-tetrachlorodibenzodioxine.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
LOC289827; UTP--glucose-1-phosphate uridylyltransferase
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
UGP2 (UDP-glucose pyrophosphorylase 2)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, Panther, Treefam
Mus musculus (house mouse):
Ugp2 (UDP-glucose pyrophosphorylase 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Ugp2 (UDP-glucose pyrophosphorylase 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
UGP2 (UDP-glucose pyrophosphorylase 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
UGP2 (UDP-glucose pyrophosphorylase 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Ugp2 (UDP-glucose pyrophosphorylase 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
UGP2 (UDP-glucose pyrophosphorylase 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
UGP2 (UDP-glucose pyrophosphorylase 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Ugp2 (UDP-glucose pyrophosphorylase 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Homo sapiens (human):
UGP2 (UDP-glucose pyrophosphorylase 2)
Alliance
DIOPT (HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Ugp2 (UDP-glucose pyrophosphorylase 2)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
ugp2b (UDP-glucose pyrophosphorylase 2b)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
ugp2a (UDP-glucose pyrophosphorylase 2a)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Saccharomyces cerevisiae (baker's yeast):
UGP1
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Caenorhabditis elegans (roundworm):
K08E3.5
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Drosophila melanogaster (fruit fly):
UGP
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):
ugp2
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 14 99,657,637 - 99,698,573 (-) NCBI GRCr8 mRatBN7.2 14 95,456,330 - 95,497,483 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 14 95,456,330 - 95,496,830 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 14 99,803,600 - 99,844,293 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 14 101,043,941 - 101,084,634 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 14 97,517,465 - 97,558,157 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 14 106,208,174 - 106,249,322 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 14 106,208,176 - 106,248,539 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 14 106,274,948 - 106,316,095 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 14 102,072,724 - 102,113,561 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 14 102,091,934 - 102,132,772 (-) NCBI Celera 14 94,469,316 - 94,509,727 (-) NCBI Celera Cytogenetic Map 14 q22 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Ugp2 Rat (S)-nicotine increases expression ISO UGP2 (Homo sapiens) 6480464 Nicotine results in increased expression of UGP2 mRNA CTD PMID:18247414 Ugp2 Rat 1,2-dimethylhydrazine multiple interactions ISO Ugp2 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UGP2 mRNA CTD PMID:22206623 Ugp2 Rat 1,2-dimethylhydrazine decreases expression ISO Ugp2 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of UGP2 mRNA CTD PMID:22206623 Ugp2 Rat 17alpha-ethynylestradiol increases expression ISO Ugp2 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of UGP2 mRNA CTD PMID:17942748 Ugp2 Rat 17alpha-ethynylestradiol multiple interactions ISO Ugp2 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UGP2 mRNA CTD PMID:17942748 Ugp2 Rat 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of UGP2 mRNA CTD PMID:32145629 Ugp2 Rat 17beta-estradiol decreases expression ISO Ugp2 (Mus musculus) 6480464 Estradiol results in decreased expression of UGP2 mRNA CTD PMID:39298647 Ugp2 Rat 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:21394737 Ugp2 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Ugp2 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UGP2 mRNA CTD PMID:17942748 Ugp2 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of UGP2 mRNA CTD PMID:34747641 Ugp2 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Ugp2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of UGP2 mRNA CTD PMID:21570461 more ... Ugp2 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of UGP2 mRNA CTD PMID:21215274 Ugp2 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Ugp2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of UGP2 mRNA CTD PMID:19770486 Ugp2 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Ugp2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of UGP2 mRNA CTD PMID:19465110 Ugp2 Rat 2,6-dimethoxyphenol multiple interactions ISO UGP2 (Homo sapiens) 6480464 [pyrogallol 1 more ... CTD PMID:38598786 Ugp2 Rat 2-bromohexadecanoic acid multiple interactions ISO UGP2 (Homo sapiens) 6480464 2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of UGP2 protein] CTD PMID:38195004 Ugp2 Rat 2-methylcholine affects expression ISO UGP2 (Homo sapiens) 6480464 beta-methylcholine affects the expression of UGP2 mRNA CTD PMID:21179406 Ugp2 Rat 2-naphthylamine increases expression ISO UGP2 (Homo sapiens) 6480464 2-Naphthylamine results in increased expression of UGP2 mRNA CTD PMID:18247414 Ugp2 Rat 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of UGP2 protein CTD PMID:34915118 Ugp2 Rat 3-phenylprop-2-enal increases expression ISO UGP2 (Homo sapiens) 6480464 cinnamaldehyde results in increased expression of UGP2 mRNA CTD PMID:17178418 Ugp2 Rat 4,4'-diaminodiphenylmethane decreases expression ISO Ugp2 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in decreased expression of UGP2 mRNA CTD PMID:18648102 Ugp2 Rat 4,4'-sulfonyldiphenol increases expression ISO UGP2 (Homo sapiens) 6480464 bisphenol S results in increased expression of UGP2 protein CTD PMID:34186270 Ugp2 Rat 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2 and 6-dinitrotoluene affects the expression of UGP2 mRNA CTD PMID:21346803 Ugp2 Rat 5-aza-2'-deoxycytidine affects expression ISO UGP2 (Homo sapiens) 6480464 Decitabine affects the expression of UGP2 mRNA CTD PMID:23300844 Ugp2 Rat 5-aza-2'-deoxycytidine multiple interactions ISO UGP2 (Homo sapiens) 6480464 Decitabine inhibits the reaction [Smoke results in decreased expression of UGP2 mRNA] CTD PMID:21095227 Ugp2 Rat acetamide decreases expression EXP 6480464 acetamide results in decreased expression of UGP2 mRNA CTD PMID:31881176 Ugp2 Rat acrolein multiple interactions ISO UGP2 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of UGP2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of UGP2 mRNA CTD PMID:32699268 Ugp2 Rat aflatoxin B1 decreases expression ISO Ugp2 (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of UGP2 mRNA CTD PMID:19770486 Ugp2 Rat all-trans-retinoic acid increases expression ISO UGP2 (Homo sapiens) 6480464 Tretinoin results in increased expression of UGP2 mRNA CTD PMID:33167477 Ugp2 Rat alpha-pinene multiple interactions ISO UGP2 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of UGP2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of UGP2 mRNA CTD PMID:32699268 Ugp2 Rat aristolochic acid A increases expression ISO UGP2 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of UGP2 protein CTD PMID:33212167 Ugp2 Rat aristolochic acid A decreases expression ISO UGP2 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of UGP2 mRNA CTD PMID:33212167 Ugp2 Rat arsenite(3-) multiple interactions ISO UGP2 (Homo sapiens) 6480464 arsenite promotes the reaction [G3BP1 protein binds to UGP2 mRNA] CTD PMID:32406909 Ugp2 Rat benzo[a]pyrene increases expression ISO UGP2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of UGP2 mRNA CTD PMID:18247414 Ugp2 Rat benzo[a]pyrene decreases expression ISO Ugp2 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of UGP2 mRNA CTD PMID:19770486 Ugp2 Rat beta-lapachone increases expression ISO UGP2 (Homo sapiens) 6480464 beta-lapachone results in increased expression of UGP2 mRNA CTD PMID:38218311 Ugp2 Rat bis(2-ethylhexyl) phthalate decreases expression ISO Ugp2 (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased expression of UGP2 mRNA CTD PMID:19850644 Ugp2 Rat bis(2-ethylhexyl) phthalate multiple interactions ISO Ugp2 (Mus musculus) 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of UGP2 mRNA] CTD PMID:19850644 Ugp2 Rat bisphenol A increases expression ISO Ugp2 (Mus musculus) 6480464 bisphenol A results in increased expression of UGP2 mRNA CTD PMID:26063408 Ugp2 Rat bisphenol A decreases expression ISO UGP2 (Homo sapiens) 6480464 bisphenol A results in decreased expression of UGP2 protein CTD PMID:34186270 Ugp2 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of UGP2 mRNA CTD PMID:32145629 and PMID:34947998 Ugp2 Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of UGP2 mRNA CTD PMID:30903817 Ugp2 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of UGP2 mRNA CTD PMID:25181051 Ugp2 Rat bisphenol AF increases expression ISO UGP2 (Homo sapiens) 6480464 bisphenol AF results in increased expression of UGP2 protein CTD PMID:34186270 Ugp2 Rat Bisphenol B increases expression ISO UGP2 (Homo sapiens) 6480464 bisphenol B results in increased expression of UGP2 protein CTD PMID:34186270 Ugp2 Rat Brodifacoum increases expression EXP 6480464 bromfenacoum results in increased expression of UGP2 protein CTD PMID:28903499 Ugp2 Rat cadmium atom multiple interactions ISO UGP2 (Homo sapiens) 6480464 2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of UGP2 protein] more ... CTD PMID:35301059 and PMID:38195004 Ugp2 Rat cadmium dichloride increases expression ISO UGP2 (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of UGP2 protein CTD PMID:24527689 Ugp2 Rat cadmium dichloride multiple interactions ISO UGP2 (Homo sapiens) 6480464 2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of UGP2 protein] more ... CTD PMID:35301059 and PMID:38195004 Ugp2 Rat cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of UGP2 mRNA CTD PMID:25993096 Ugp2 Rat carbon nanotube decreases expression ISO Ugp2 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25620056 Ugp2 Rat chenodeoxycholic acid multiple interactions ISO UGP2 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of UGP2 mRNA and [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of UGP2 mRNA CTD PMID:33819548 Ugp2 Rat chlorpyrifos decreases expression ISO Ugp2 (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of UGP2 mRNA CTD PMID:37019170 Ugp2 Rat cisplatin affects expression ISO UGP2 (Homo sapiens) 6480464 Cisplatin affects the expression of UGP2 mRNA CTD PMID:23300844 Ugp2 Rat clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of UGP2 protein CTD PMID:16470657 Ugp2 Rat clofibrate decreases expression ISO Ugp2 (Mus musculus) 6480464 Clofibrate results in decreased expression of UGP2 mRNA CTD PMID:23811191 Ugp2 Rat clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of UGP2 mRNA CTD PMID:17602206 Ugp2 Rat copper(II) chloride increases expression ISO UGP2 (Homo sapiens) 6480464 cupric chloride results in increased expression of UGP2 mRNA CTD PMID:38568856 Ugp2 Rat copper(II) sulfate decreases expression ISO UGP2 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of UGP2 mRNA CTD PMID:19549813 Ugp2 Rat crocidolite asbestos affects expression ISO UGP2 (Homo sapiens) 6480464 Asbestos and Crocidolite affects the expression of UGP2 mRNA CTD PMID:24160326 Ugp2 Rat cyclosporin A decreases expression ISO Ugp2 (Mus musculus) 6480464 Cyclosporine results in decreased expression of UGP2 mRNA CTD PMID:19770486 Ugp2 Rat cyclosporin A multiple interactions ISO UGP2 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of UGP2 mRNA CTD PMID:33819548 Ugp2 Rat cyclosporin A increases expression ISO UGP2 (Homo sapiens) 6480464 Cyclosporine results in increased expression of UGP2 mRNA CTD PMID:25562108 Ugp2 Rat deoxycholic acid multiple interactions ISO UGP2 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of UGP2 mRNA and [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of UGP2 mRNA CTD PMID:33819548 Ugp2 Rat dexamethasone increases expression ISO UGP2 (Homo sapiens) 6480464 Dexamethasone results in increased expression of UGP2 mRNA CTD PMID:25047013 Ugp2 Rat Dibutyl phosphate affects expression ISO UGP2 (Homo sapiens) 6480464 di-n-butylphosphoric acid affects the expression of UGP2 mRNA CTD PMID:37042841 Ugp2 Rat dibutyl phthalate decreases expression ISO Ugp2 (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of UGP2 mRNA CTD PMID:21266533 Ugp2 Rat dichlorvos decreases activity EXP 6480464 Dichlorvos results in decreased activity of UGP2 protein CTD PMID:222008 Ugp2 Rat dicrotophos decreases expression ISO UGP2 (Homo sapiens) 6480464 dicrotophos results in decreased expression of UGP2 mRNA CTD PMID:28302478 Ugp2 Rat dorsomorphin multiple interactions ISO UGP2 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Ugp2 Rat ellagic acid decreases expression ISO UGP2 (Homo sapiens) 6480464 Ellagic Acid results in decreased expression of UGP2 mRNA CTD PMID:12002526 Ugp2 Rat entinostat increases expression ISO UGP2 (Homo sapiens) 6480464 entinostat results in increased expression of UGP2 mRNA CTD PMID:26272509 Ugp2 Rat entinostat multiple interactions ISO UGP2 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UGP2 mRNA CTD PMID:27188386 Ugp2 Rat ethanol affects expression ISO Ugp2 (Mus musculus) 6480464 Ethanol affects the expression of UGP2 mRNA CTD PMID:30319688 Ugp2 Rat flucloxacillin affects binding ISO UGP2 (Homo sapiens) 6480464 Floxacillin binds to UGP2 protein CTD PMID:36782357 Ugp2 Rat flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of UGP2 mRNA CTD PMID:24793618 Ugp2 Rat folic acid multiple interactions ISO Ugp2 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UGP2 mRNA CTD PMID:22206623 Ugp2 Rat FR900359 increases phosphorylation ISO UGP2 (Homo sapiens) 6480464 FR900359 results in increased phosphorylation of UGP2 protein CTD PMID:37730182 Ugp2 Rat furfural multiple interactions ISO UGP2 (Homo sapiens) 6480464 [pyrogallol 1 more ... CTD PMID:38598786 Ugp2 Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of UGP2 mRNA CTD PMID:22061828 Ugp2 Rat glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of UGP2 mRNA CTD PMID:24136188 Ugp2 Rat glycochenodeoxycholic acid multiple interactions ISO UGP2 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of UGP2 mRNA and [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of UGP2 mRNA CTD PMID:33819548 Ugp2 Rat glycocholic acid multiple interactions ISO UGP2 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of UGP2 mRNA and [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of UGP2 mRNA CTD PMID:33819548 Ugp2 Rat glycodeoxycholic acid multiple interactions ISO UGP2 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of UGP2 mRNA and [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of UGP2 mRNA CTD PMID:33819548 Ugp2 Rat haloperidol increases expression ISO UGP2 (Homo sapiens) 6480464 Haloperidol results in increased expression of UGP2 protein CTD PMID:34122009 Ugp2 Rat ivermectin affects expression ISO UGP2 (Homo sapiens) 6480464 Ivermectin affects the expression of UGP2 protein CTD PMID:32959892 Ugp2 Rat microcystin-LR increases expression ISO Ugp2 (Mus musculus) 6480464 cyanoginosin LR results in increased expression of UGP2 mRNA CTD PMID:17654400 Ugp2 Rat N-methylformamide increases expression ISO Ugp2 (Mus musculus) 6480464 methylformamide analog results in increased expression of UGP2 mRNA and methylformamide results in increased expression of UGP2 mRNA CTD PMID:17040096 Ugp2 Rat N-nitrosodiethylamine multiple interactions EXP 6480464 [Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of UGP2 protein CTD PMID:20935162 Ugp2 Rat nicotine increases expression ISO UGP2 (Homo sapiens) 6480464 Nicotine results in increased expression of UGP2 mRNA CTD PMID:18247414 Ugp2 Rat nitrofen increases expression EXP 6480464 nitrofen results in increased expression of UGP2 mRNA CTD PMID:33484710 Ugp2 Rat obeticholic acid increases expression ISO UGP2 (Homo sapiens) 6480464 obeticholic acid results in increased expression of UGP2 mRNA CTD PMID:27939613 Ugp2 Rat ozone multiple interactions ISO UGP2 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of UGP2 mRNA more ... CTD PMID:32699268 and PMID:35430440 Ugp2 Rat paracetamol decreases expression ISO UGP2 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of UGP2 mRNA CTD PMID:21420995 and PMID:29067470 Ugp2 Rat paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of UGP2 mRNA CTD PMID:33387578 Ugp2 Rat paracetamol multiple interactions ISO UGP2 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of UGP2 mRNA CTD PMID:33819548 Ugp2 Rat perfluorohexanesulfonic acid increases expression ISO Ugp2 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in increased expression of UGP2 mRNA CTD PMID:37995155 Ugp2 Rat perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of UGP2 protein CTD PMID:34958885 Ugp2 Rat phenobarbital multiple interactions EXP 6480464 [Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of UGP2 protein CTD PMID:20935162 Ugp2 Rat pirinixic acid multiple interactions ISO Ugp2 (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of UGP2 mRNA CTD PMID:19710929 Ugp2 Rat pirinixic acid decreases expression ISO Ugp2 (Mus musculus) 6480464 pirinixic acid results in decreased expression of UGP2 mRNA CTD PMID:18445702 more ... Ugp2 Rat quercetin decreases expression ISO UGP2 (Homo sapiens) 6480464 Quercetin results in decreased expression of UGP2 mRNA CTD PMID:21632981 Ugp2 Rat resveratrol decreases expression ISO UGP2 (Homo sapiens) 6480464 resveratrol results in decreased expression of UGP2 mRNA CTD PMID:12002526 Ugp2 Rat resveratrol multiple interactions ISO UGP2 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of UGP2 mRNA CTD PMID:23557933 Ugp2 Rat SB 431542 multiple interactions ISO UGP2 (Homo sapiens) 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 and PMID:37664457 Ugp2 Rat serpentine asbestos affects expression ISO UGP2 (Homo sapiens) 6480464 Asbestos and Serpentine affects the expression of UGP2 mRNA CTD PMID:24160326 Ugp2 Rat sodium arsenate increases expression ISO Ugp2 (Mus musculus) 6480464 sodium arsenate results in increased expression of UGP2 mRNA CTD PMID:21795629 Ugp2 Rat sodium arsenate decreases expression ISO Ugp2 (Mus musculus) 6480464 sodium arsenate results in decreased expression of UGP2 mRNA CTD PMID:30953684 Ugp2 Rat sodium chloride multiple interactions ISO UGP2 (Homo sapiens) 6480464 [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of UGP2 protein more ... CTD PMID:38598786 Ugp2 Rat sunitinib decreases expression ISO UGP2 (Homo sapiens) 6480464 Sunitinib results in decreased expression of UGP2 mRNA CTD PMID:31533062 Ugp2 Rat tanespimycin decreases expression ISO UGP2 (Homo sapiens) 6480464 tanespimycin results in decreased expression of UGP2 protein CTD PMID:31370342 Ugp2 Rat tetrachloromethane affects expression ISO Ugp2 (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of UGP2 mRNA CTD PMID:17484886 Ugp2 Rat thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of UGP2 mRNA CTD PMID:34492290 Ugp2 Rat thiram increases expression ISO UGP2 (Homo sapiens) 6480464 Thiram results in increased expression of UGP2 mRNA CTD PMID:38568856 Ugp2 Rat titanium dioxide decreases methylation ISO Ugp2 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of UGP2 gene and titanium dioxide results in decreased methylation of UGP2 promoter CTD PMID:35295148 Ugp2 Rat trichostatin A decreases expression ISO UGP2 (Homo sapiens) 6480464 trichostatin A results in decreased expression of UGP2 mRNA CTD PMID:24935251 Ugp2 Rat trichostatin A increases expression ISO UGP2 (Homo sapiens) 6480464 trichostatin A results in increased expression of UGP2 mRNA CTD PMID:24935251 Ugp2 Rat triclosan decreases expression ISO UGP2 (Homo sapiens) 6480464 Triclosan results in decreased expression of UGP2 mRNA CTD PMID:30510588 Ugp2 Rat troglitazone decreases expression ISO Ugp2 (Mus musculus) 6480464 troglitazone results in decreased expression of UGP2 mRNA CTD PMID:28973697 Ugp2 Rat valproic acid affects expression ISO Ugp2 (Mus musculus) 6480464 Valproic Acid affects the expression of UGP2 mRNA CTD PMID:17963808 Ugp2 Rat valproic acid multiple interactions ISO UGP2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UGP2 mRNA CTD PMID:27188386 Ugp2 Rat valproic acid affects expression ISO UGP2 (Homo sapiens) 6480464 Valproic Acid affects the expression of UGP2 mRNA CTD PMID:25979313 Ugp2 Rat valproic acid decreases expression ISO UGP2 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of UGP2 mRNA CTD PMID:24935251 Ugp2 Rat vancomycin increases expression ISO Ugp2 (Mus musculus) 6480464 Vancomycin results in increased expression of UGP2 mRNA CTD PMID:18930951 Ugp2 Rat vanillin increases expression ISO UGP2 (Homo sapiens) 6480464 vanillin results in increased expression of UGP2 mRNA CTD PMID:17178418 Ugp2 Rat vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of UGP2 mRNA CTD PMID:23034163 more ...
Imported Annotations - SMPDB
Imported Annotations - KEGG (archival)
(S)-nicotine (ISO) 1,2-dimethylhydrazine (ISO) 17alpha-ethynylestradiol (ISO) 17beta-estradiol (EXP,ISO) 2,2',4,4'-Tetrabromodiphenyl ether (EXP) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,6-dimethoxyphenol (ISO) 2-bromohexadecanoic acid (ISO) 2-methylcholine (ISO) 2-naphthylamine (ISO) 3-chloropropane-1,2-diol (EXP) 3-phenylprop-2-enal (ISO) 4,4'-diaminodiphenylmethane (ISO) 4,4'-sulfonyldiphenol (ISO) 4-amino-2,6-dinitrotoluene (EXP) 5-aza-2'-deoxycytidine (ISO) acetamide (EXP) acrolein (ISO) aflatoxin B1 (ISO) all-trans-retinoic acid (ISO) alpha-pinene (ISO) aristolochic acid A (ISO) arsenite(3-) (ISO) benzo[a]pyrene (ISO) beta-lapachone (ISO) bis(2-ethylhexyl) phthalate (ISO) bisphenol A (EXP,ISO) bisphenol AF (ISO) Bisphenol B (ISO) Brodifacoum (EXP) cadmium atom (ISO) cadmium dichloride (EXP,ISO) carbon nanotube (ISO) chenodeoxycholic acid (ISO) chlorpyrifos (ISO) cisplatin (ISO) clofibrate (EXP,ISO) clofibric acid (EXP) copper(II) chloride (ISO) copper(II) sulfate (ISO) crocidolite asbestos (ISO) cyclosporin A (ISO) deoxycholic acid (ISO) dexamethasone (ISO) Dibutyl phosphate (ISO) dibutyl phthalate (ISO) dichlorvos (EXP) dicrotophos (ISO) dorsomorphin (ISO) ellagic acid (ISO) entinostat (ISO) ethanol (ISO) flucloxacillin (ISO) flutamide (EXP) folic acid (ISO) FR900359 (ISO) furfural (ISO) gentamycin (EXP) glafenine (EXP) glycochenodeoxycholic acid (ISO) glycocholic acid (ISO) glycodeoxycholic acid (ISO) haloperidol (ISO) ivermectin (ISO) microcystin-LR (ISO) N-methylformamide (ISO) N-nitrosodiethylamine (EXP) nicotine (ISO) nitrofen (EXP) obeticholic acid (ISO) ozone (ISO) paracetamol (EXP,ISO) perfluorohexanesulfonic acid (ISO) perfluorooctanoic acid (EXP) phenobarbital (EXP) pirinixic acid (ISO) quercetin (ISO) resveratrol (ISO) SB 431542 (ISO) serpentine asbestos (ISO) sodium arsenate (ISO) sodium chloride (ISO) sunitinib (ISO) tanespimycin (ISO) tetrachloromethane (ISO) thioacetamide (EXP) thiram (ISO) titanium dioxide (ISO) trichostatin A (ISO) triclosan (ISO) troglitazone (ISO) valproic acid (ISO) vancomycin (ISO) vanillin (ISO) vinclozolin (EXP)
Ugp2 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 14 99,657,637 - 99,698,573 (-) NCBI GRCr8 mRatBN7.2 14 95,456,330 - 95,497,483 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 14 95,456,330 - 95,496,830 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 14 99,803,600 - 99,844,293 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 14 101,043,941 - 101,084,634 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 14 97,517,465 - 97,558,157 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 14 106,208,174 - 106,249,322 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 14 106,208,176 - 106,248,539 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 14 106,274,948 - 106,316,095 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 14 102,072,724 - 102,113,561 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 14 102,091,934 - 102,132,772 (-) NCBI Celera 14 94,469,316 - 94,509,727 (-) NCBI Celera Cytogenetic Map 14 q22 NCBI
UGP2 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 2 63,840,969 - 63,891,560 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 2 63,840,952 - 63,891,562 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 2 64,068,103 - 64,118,694 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 2 63,921,602 - 63,972,200 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 2 63,980,664 - 64,030,346 NCBI Celera 2 63,913,075 - 63,963,963 (+) NCBI Celera Cytogenetic Map 2 p15 NCBI HuRef 2 63,807,585 - 63,858,409 (+) NCBI HuRef CHM1_1 2 63,998,438 - 64,048,971 (+) NCBI CHM1_1 T2T-CHM13v2.0 2 63,848,515 - 63,899,116 (+) NCBI T2T-CHM13v2.0
Ugp2 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 11 21,271,126 - 21,321,267 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 11 21,271,138 - 21,321,201 (-) Ensembl GRCm39 Ensembl GRCm38 11 21,321,126 - 21,371,267 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 11 21,321,138 - 21,371,201 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 11 21,221,141 - 21,270,882 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 11 21,221,147 - 21,270,478 (-) NCBI MGSCv36 mm8 Celera 11 23,469,505 - 23,519,228 (-) NCBI Celera Cytogenetic Map 11 A3.1 NCBI cM Map 11 13.89 NCBI
Ugp2 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955424 20,444,405 - 20,490,379 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955424 20,444,974 - 20,490,016 (-) NCBI ChiLan1.0 ChiLan1.0
UGP2 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 12 62,507,777 - 62,560,210 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 2A 62,511,728 - 62,564,161 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 2A 63,906,778 - 63,959,346 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 2A 65,032,218 - 65,084,510 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 2A 65,043,871 - 65,084,175 (+) Ensembl panpan1.1 panPan2
UGP2 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 10 63,532,366 - 63,598,362 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 10 63,533,171 - 63,597,452 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 10 63,421,118 - 63,487,241 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 10 64,541,209 - 64,607,376 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 10 64,541,236 - 64,607,362 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 10 64,223,314 - 64,289,173 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 10 64,531,998 - 64,598,118 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 10 64,824,849 - 64,890,750 (+) NCBI UU_Cfam_GSD_1.0
Ugp2 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024406292 19,736,308 - 19,797,383 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936491 8,773,892 - 8,837,661 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936491 8,773,910 - 8,834,984 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
UGP2 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 3 77,975,441 - 78,031,703 (-) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 3 77,975,450 - 78,032,471 (-) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 3 81,978,534 - 82,014,755 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
UGP2 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 14 43,127,718 - 43,181,348 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 14 43,128,055 - 43,180,569 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666045 68,680,450 - 68,734,106 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Ugp2 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 47 Count of miRNA genes: 39 Interacting mature miRNAs: 45 Transcripts: ENSRNOT00000067668 Prediction methods: Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
1582201 Sffal2 Serum free fatty acids level QTL 2 4 0.0002 blood free fatty acid amount (VT:0001553) serum free fatty acids level (CMO:0000547) 14 92553886 95876975 Rat 9590294 Uminl4 Urine mineral level QTL 4 5.66 0.001 urine mineral amount (VT:0015086) urine electrolyte level (CMO:0000593) 14 55624247 100624247 Rat 631213 Bw60 Body weight QTL60 4.51 retroperitoneal fat pad mass (VT:0010430) retroperitoneal fat pad weight to body weight ratio (CMO:0000635) 14 79950921 95876975 Rat 2300197 Scl59 Serum cholesterol level QTL 59 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 14 55147478 100147478 Rat 631523 Pia13 Pristane induced arthritis QTL 13 3.3 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 14 40793460 98037301 Rat 1582259 Gluco23 Glucose level QTL 23 3.1 0.0008 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 14 70053989 104886043 Rat 634328 Hc5 Hypercalciuria QTL 5 2.3 urine calcium amount (VT:0002985) urine calcium excretion rate (CMO:0000763) 14 58184885 103184885 Rat 1582250 Gluco26 Glucose level QTL 26 3.3 0.0009 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 14 73415323 95876975 Rat 2317879 Alcrsp27 Alcohol response QTL 27 3.3 0.63 response to alcohol trait (VT:0010489) duration of loss of righting reflex (CMO:0002289) 14 56631369 101631369 Rat 1641900 Alcrsp11 Alcohol response QTL 11 alcohol metabolism trait (VT:0015089) blood ethanol level (CMO:0000535) 14 70053989 104886043 Rat 4889951 Bss92 Bone structure and strength QTL 92 3.9 tibia area (VT:1000281) tibia-fibula cortical bone total cross-sectional area (CMO:0001721) 14 82057471 95876975 Rat 631839 Niddm37 Non-insulin dependent diabetes mellitus QTL 37 3.37 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 14 11030622 95876975 Rat 9589034 Epfw11 Epididymal fat weight QTL 11 6 0.001 epididymal fat pad mass (VT:0010421) epididymal fat pad weight to body weight ratio (CMO:0000658) 14 55624247 100624247 Rat
RH133427
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 14 95,456,412 - 95,456,608 (+) MAPPER mRatBN7.2 Rnor_6.0 14 106,208,257 - 106,208,452 NCBI Rnor6.0 Rnor_5.0 14 106,275,031 - 106,275,226 UniSTS Rnor5.0 RGSC_v3.4 14 102,072,805 - 102,073,000 UniSTS RGSC3.4 Celera 14 94,469,397 - 94,469,592 UniSTS RH 3.4 Map 14 755.3 UniSTS Cytogenetic Map 14 q22 UniSTS
BF402398
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 14 95,461,952 - 95,462,049 (+) MAPPER mRatBN7.2 Rnor_6.0 14 106,213,797 - 106,213,893 NCBI Rnor6.0 Rnor_5.0 14 106,280,571 - 106,280,667 UniSTS Rnor5.0 RGSC_v3.4 14 102,078,346 - 102,078,442 UniSTS RGSC3.4 Celera 14 94,474,937 - 94,475,033 UniSTS RH 3.4 Map 14 755.6 UniSTS Cytogenetic Map 14 q22 UniSTS
RH141780
Rat Assembly Chr Position (strand) Source JBrowse RH 3.4 Map 14 753.7 UniSTS Cytogenetic Map 14 q22 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000067668 ⟹ ENSRNOP00000063786
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 14 95,456,335 - 95,496,830 (-) Ensembl Rnor_6.0 Ensembl 14 106,208,176 - 106,248,539 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000081245 ⟹ ENSRNOP00000073284
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 14 95,456,330 - 95,482,001 (-) Ensembl Rnor_6.0 Ensembl 14 106,208,514 - 106,234,247 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000105335 ⟹ ENSRNOP00000095723
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 14 95,462,135 - 95,496,830 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000106549 ⟹ ENSRNOP00000081370
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 14 95,456,330 - 95,482,402 (-) Ensembl
RefSeq Acc Id:
NM_001024743 ⟹ NP_001019914
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 99,657,639 - 99,698,002 (-) NCBI mRatBN7.2 14 95,456,332 - 95,496,695 (-) NCBI Rnor_6.0 14 106,208,176 - 106,248,539 (-) NCBI Rnor_5.0 14 106,274,948 - 106,316,095 (-) NCBI RGSC_v3.4 14 102,072,724 - 102,113,561 (-) RGD Celera 14 94,469,316 - 94,509,727 (-) RGD
Sequence:
CGGGATCGCTGAGTAGCCAGGAGTTCCCTCCCAAGCTGAGTCGGTCCCACCAAGTTTCCGTCTTCTGGATTTTTCTTTTTAAAGACCAGTTTTGATCCCCCCCCCCTCCCGAATACTTCCTTAAGTAG CTAAACAGCGGAGGAGAAAGAACACTTCGGTTGTTGCAGGGAAGGGAGAGAGACCTTTCTTACAACGCAGCTTCTAGAAATTGAAAATTATAAGGCAGATTATTTTAATAAAATCCTAAAATGTCGAG ATTTGTACAAGATCTTAGCAAAGCTATGTCTCAAGATGGTGCTTCTCAGTTCCAAGAGGTCATTCTCCAAGAACTAGAATTATCTGTGAAGAAAGAATTAGAAAAAATACTTACCACAGCAACCTCAC ATGAGTTTGAGCACACTAAGAAAGATCTTGATGGATTTCGGAAGCTATTTCACAGATTTTTGCAAGAAAAGGGGCCTTCTGTAGACTGGGGTAAAATCCAGAGACCTCCGGAAGATTCGATTCAACCC TATGAAAAGATAAAGGCCAGAGGCTTGCCTGATAACATATCTTCTGTGTTGAACAAACTGGTGGTAGTGAAACTCAATGGTGGTTTGGGAACCAGCATGGGCTGCAAAGGCCCTAAAAGTCTGATTGG TGTAAGAAATGAGAATACCTTTTTGGATCTAACCGTTCAGCAAATTGAACATCTGAACAAAACCTATAATACAGATGTCCCGCTCGTATTAATGAATTCTTTTAACACGGATGAGGATACAAAAAAAA TACTCCAGAAGTACAATCATTGTCGTGTGAAAATCTACACCTTCAATCAAAGCAGGTACCCGAGGATTAATAAGGAATCTCTACTTCCTATAGCAAAGGACGTATCTTATTCAGGGGAAAATACTGAA GCTTGGTACCCTCCAGGACATGGGGACATCTATGCCAGTTTCTACAACTCTGGTTTGCTCGACACCTTCATAGAAGAAGGCAAGGAGTATATTTTTGTGTCTAACATAGACAACCTGGGTGCCACAGT GGATCTTTATATTCTTAATCATCTAATGAACCCACCCAATGGGAAACGCTGTGAATTTGTCATGGAAGTCACAAATAAAACACGGGCAGACGTAAAGGGTGGGACACTCACTCAGTACGAAGGCAAAC TGAGGCTGGTGGAGATTGCTCAGGTGCCCAAAGCACACGTTGATGAGTTCAAGTCTGTGTCAAAATTTAAAATATTTAACACAAACAACCTATGGATCTCCCTGGCCGCCGTTAAAAGACTGCAGGAA CAGAATGCTATTGACATGGAAATCATTGTGAACCCAAAGACATTGGATGGAGGCCTGAATGTTATTCAGTTAGAAACTGCAGTTGGAGCGGCAATTAAAAGTTTCGAGAATTCTTTAGGTATTAATGT TCCAAGGAGTCGTTTTCTGCCTGTGAAAACCACATCAGATCTCTTACTTGTGATGTCAAACCTCTACAGCCTTAACGCAGGATCTTTGACCATGAGTGAAAAGCGTGAATTTCCTACGGTACCTTTGG TTAAATTAGGCAGTTCTTTTACCAAGGTTCAAGATTATCTAAGAAGGTTTGAAAGTATACCCGATATGTTGGAACTGGACCACCTCACGGTTTCAGGAGATGTAACATTTGGAAAAAATGTTTCATTA AAGGGAACAGTTATCATCATTGCAAATCATGGTGACAGAATTGACATCCCCCCAGGAGCAGTGTTAGAGAACAAGATTGTATCTGGGAACCTTCGGATCCTGGACCACTGAAATGAGCACTGTCAGCT ACACTTTCTACTAATTATGGGCTAAAGAGTTTTACAATAAAATGTCCTCAGATTATAAAGCAAGCAGGTACTTTATTTACTATGTTGTACTCTGCACTATTGATTTTTAAAGTAGTTTTCTGCAATGA GCTTTTAGTCTAAGGAAAGCCTAAACAAAGCAATACTTTCCTTCTTGGATGAAAAGCCTAGAAATTAGGTCCTCTTAAAGTGCAATATTATTTAATCTCAGAATCGGGCCAGCTCTGTAGATCTTCAA CAGAAGCTTCAGTGACTGTCCCTTTGAATTGCCTTTGATTTCAAAAATAAAAAGATCCATGTGTTAAAAAAAAAAAAAAAAAAAAAAAAA
hide sequence
RefSeq Acc Id:
XM_006251538 ⟹ XP_006251600
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 99,657,637 - 99,698,573 (-) NCBI mRatBN7.2 14 95,456,330 - 95,497,483 (-) NCBI Rnor_6.0 14 106,208,174 - 106,249,322 (-) NCBI Rnor_5.0 14 106,274,948 - 106,316,095 (-) NCBI
Sequence:
CCGCATTGGGGGGAGAAGAAGGGGGAGGGGAGGTGTGTGGAGAAAGTGGGGGCTCCGGTTTCGGGAGGAGGGTCACCGGCTGCGCACGCTGGCGCCGGGCTCCAGGTATTTGCGTGTGACCGGAGCGC AGGGGAGGCCGCCTCGGCCACGCTCGCGCAGCGCAGCCTTCGAGACCTGATTCCAGGCCCCCAACCACCCAGCCAGCCACGGAAGAGGAAGATCTTAGCAAAGCTATGTCTCAAGATGGTGCTTCTCA GTTCCAAGAGGTCATTCTCCAAGAACTAGAATTATCTGTGAAGAAAGAATTAGAAAAAATACTTACCACAGCAACCTCACATGAGTTTGAGCACACTAAGAAAGATCTTGATGGATTTCGGAAGCTAT TTCACAGATTTTTGCAAGAAAAGGGGCCTTCTGTAGACTGGGGTAAAATCCAGAGACCTCCGGAAGATTCGATTCAACCCTATGAAAAGATAAAGGCCAGAGGCTTGCCTGATAACATATCTTCTGTG TTGAACAAACTGGTGGTAGTGAAACTCAATGGTGGTTTGGGAACCAGCATGGGCTGCAAAGGCCCTAAAAGTCTGATTGGTGTAAGAAATGAGAATACCTTTTTGGATCTAACCGTTCAGCAAATTGA ACATCTGAACAAAACCTATAATACAGATGTCCCGCTCGTATTAATGAATTCTTTTAACACGGATGAGGATACAAAAAAAATACTCCAGAAGTACAATCATTGTCGTGTGAAAATCTACACCTTCAATC AAAGCAGGTACCCGAGGATTAATAAGGAATCTCTACTTCCTATAGCAAAGGACGTATCTTATTCAGGGGAAAATACTGAAGCTTGGTACCCTCCAGGACATGGGGACATCTATGCCAGTTTCTACAAC TCTGGTTTGCTCGACACCTTCATAGAAGAAGGCAAGGAGTATATTTTTGTGTCTAACATAGACAACCTGGGTGCCACAGTGGATCTTTATATTCTTAATCATCTAATGAACCCACCCAATGGGAAACG CTGTGAATTTGTCATGGAAGTCACAAATAAAACACGGGCAGACGTAAAGGGTGGGACACTCACTCAGTACGAAGGCAAACTGAGGCTGGTGGAGATTGCTCAGGTGCCCAAAGCACACGTTGATGAGT TCAAGTCTGTGTCAAAATTTAAAATATTTAACACAAACAACCTATGGATCTCCCTGGCCGCCGTTAAAAGACTGCAGGAACAGAATGCTATTGACATGGAAATCATTGTGAACCCAAAGACATTGGAT GGAGGCCTGAATGTTATTCAGTTAGAAACTGCAGTTGGAGCGGCAATTAAAAGTTTCGAGAATTCTTTAGGTATTAATGTTCCAAGGAGTCGTTTTCTGCCTGTGAAAACCACATCAGATCTCTTACT TGTGATGTCAAACCTCTACAGCCTTAACGCAGGATCTTTGACCATGAGTGAAAAGCGTGAATTTCCTACGGTACCTTTGGTTAAATTAGGCAGTTCTTTTACCAAGGTTCAAGATTATCTAAGAAGGT TTGAAAGTATACCCGATATGTTGGAACTGGACCACCTCACGGTTTCAGGAGATGTAACATTTGGAAAAAATGTTTCATTAAAGGGAACAGTTATCATCATTGCAAATCATGGTGACAGAATTGACATC CCCCCAGGAGCAGTGTTAGAGAACAAGATTGTATCTGGGAACCTTCGGATCCTGGACCACTGAAATGAGCACTGTCAGCTACACTTTCTACTAATTATGGGCTAAAGAGTTTTACAATAAAATGTCCT CAGATTATAAAGCAAGCAGGTACTTTATTTACTATGTTGTACTCTGCACTATTGATTTTTAAAGTAGTTTTCTGCAATGAGCTTTTAGTCTAAGGAAAGCCTAAACAAAGCAATACTTTCCTTCTTGG ATGAAAAGCCTAGAAATTAGGTCCTCTTAAAGTGCAATATTATTTAATCTCAGAATCGGGCCAGCTCTGTAGATCTTCAACAGAAGCTTCAGTGACTGTCCCTTTGAATTGCCTTTGATTTCAAAAAT AAAAAGATCCATGTGTTCA
hide sequence
RefSeq Acc Id:
NP_001019914 ⟸ NM_001024743
- UniProtKB:
Q4V8I9 (UniProtKB/TrEMBL), F1LQ84 (UniProtKB/TrEMBL), A0A9K3Y8H8 (UniProtKB/TrEMBL), A0A0G2K542 (UniProtKB/TrEMBL)
- Sequence:
MSRFVQDLSKAMSQDGASQFQEVILQELELSVKKELEKILTTATSHEFEHTKKDLDGFRKLFHRFLQEKGPSVDWGKIQRPPEDSIQPYEKIKARGLPDNISSVLNKLVVVKLNGGLGTSMGCKGPKS LIGVRNENTFLDLTVQQIEHLNKTYNTDVPLVLMNSFNTDEDTKKILQKYNHCRVKIYTFNQSRYPRINKESLLPIAKDVSYSGENTEAWYPPGHGDIYASFYNSGLLDTFIEEGKEYIFVSNIDNLG ATVDLYILNHLMNPPNGKRCEFVMEVTNKTRADVKGGTLTQYEGKLRLVEIAQVPKAHVDEFKSVSKFKIFNTNNLWISLAAVKRLQEQNAIDMEIIVNPKTLDGGLNVIQLETAVGAAIKSFENSLG INVPRSRFLPVKTTSDLLLVMSNLYSLNAGSLTMSEKREFPTVPLVKLGSSFTKVQDYLRRFESIPDMLELDHLTVSGDVTFGKNVSLKGTVIIIANHGDRIDIPPGAVLENKIVSGNLRILDH
hide sequence
RefSeq Acc Id:
XP_006251600 ⟸ XM_006251538
- Peptide Label:
isoform X1
- Sequence:
MSQDGASQFQEVILQELELSVKKELEKILTTATSHEFEHTKKDLDGFRKLFHRFLQEKGPSVDWGKIQRPPEDSIQPYEKIKARGLPDNISSVLNKLVVVKLNGGLGTSMGCKGPKSLIGVRNENTFL DLTVQQIEHLNKTYNTDVPLVLMNSFNTDEDTKKILQKYNHCRVKIYTFNQSRYPRINKESLLPIAKDVSYSGENTEAWYPPGHGDIYASFYNSGLLDTFIEEGKEYIFVSNIDNLGATVDLYILNHL MNPPNGKRCEFVMEVTNKTRADVKGGTLTQYEGKLRLVEIAQVPKAHVDEFKSVSKFKIFNTNNLWISLAAVKRLQEQNAIDMEIIVNPKTLDGGLNVIQLETAVGAAIKSFENSLGINVPRSRFLPV KTTSDLLLVMSNLYSLNAGSLTMSEKREFPTVPLVKLGSSFTKVQDYLRRFESIPDMLELDHLTVSGDVTFGKNVSLKGTVIIIANHGDRIDIPPGAVLENKIVSGNLRILDH
hide sequence
Ensembl Acc Id:
ENSRNOP00000063786 ⟸ ENSRNOT00000067668
Ensembl Acc Id:
ENSRNOP00000073284 ⟸ ENSRNOT00000081245
Ensembl Acc Id:
ENSRNOP00000081370 ⟸ ENSRNOT00000106549
Ensembl Acc Id:
ENSRNOP00000095723 ⟸ ENSRNOT00000105335
RGD ID: 13699514
Promoter ID: EPDNEW_R10038
Type: multiple initiation site
Name: Ugp2_1
Description: UDP-glucose pyrophosphorylase 2
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 14 106,248,567 - 106,248,627 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2005-12-06
Ugp2
UDP-glucose pyrophosphorylase 2
Ugp2_predicted
UDP-glucose pyrophosphorylase 2 (predicted)
Symbol and Name updated
1559027
APPROVED
2005-01-12
Ugp2_predicted
UDP-glucose pyrophosphorylase 2 (predicted)
Symbol and Name status set to approved
70820
APPROVED